Requirements for Successful Completion: Complete the learning activity in its entirety and complete the online CNE evaluation.
Authors Conflict of Interest Disclosure: The author(s), editor, editorial board, content reviewers, and education director reported no actual or potential conflict of interest in relation to this continuing nursing education article.
Commercial Support and Sponsorship: No commercial support or sponsorship declared.
Accreditation Statement: This educational activity is jointly provided by Anthony J. Jannetti, Inc. and the Academy of Medical Surgical Nurses (AMSN).
Anthony J. Jannetti, Inc. is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.
Anthony J. Jannetti, Inc. is a provider approved by the California Board of Registered Nursing, provider number CEP 5387. Licensees in the state of California must retain this certificate for four years after the CNE activity is completed.
This article was reviewed and formatted for contact hour credit by Rosemarie Marmion, MSN, RN-BC, NE-BC, AMSN Education Director.
Learning Outcome: After completing this learning activity, the learner will be able to discuss antiviral medications used to treat hepatitis C.
Antiviral Medications, Part 4: Evidence-Based Treatment of Hepatitis C
1.20 - CH
1.20 - Rx
You must be logged in and own this product in order to post comments.
3/3/18 1:52 am
The ariticle gives me some impressive information, Thank you.
3/8/18 11:38 pm
Importance of napping or rest and drinking 6 to 8 glasses of water during treatment.
4/10/18 5:12 pm
The improvement of Hepatitis C with medications. The medications help remove the virus. It is important for the patient to remain active. Educate the patient on the medications.
4/12/18 11:37 pm
The article is very educative and informative.
8/13/18 6:26 pm
Having the goal of HCV treatment be "to reduce incidence of hepatic-associated complications and mortality", and the resulting "significant improvement" should be encouraging, but it still comes down to patient adherence to be successful. If 60% of acute HCV infections are due to IV drug use, patient adherence is a heavy weight to try to float.
11/30/18 5:49 am
interferon-based therapies can cause adverse reactions such as bone marrow depression which leads to anemia, neutropenia, and thrombocytopenia; signs of infection depression, leading to suicide.